European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

An integrated POC solution for non-invasive diagnosis and therapy monitoring of Heart Failure patients

Descripción del proyecto

Diagnóstico de la insuficiencia cardiaca en el punto de atención basado en la saliva

La insuficiencia cardiaca constituye un problema sanitario mundial, con una prevalencia creciente y un mal pronóstico. Sin embargo, su diagnóstico y seguimiento terapéutico carecen de herramientas personalizadas y fiables. Para hacer frente a estos retos, en el proyecto KardiaTool, financiado con fondos europeos, se pretende desarrollar un dispositivo portátil capaz de diagnosticar la insuficiencia cardíaca y supervisar el tratamiento en el punto de atención utilizando muestras de saliva. El dispositivo incorporará distintos biomarcadores salivales de la insuficiencia cardiaca, lo que ofrecerá una alternativa rentable al análisis de sangre. Se espera que la comodidad de manejo y el potencial de supervisión continua que ofrece la tecnología KardiaTool mejoren la práctica clínica y el cuidado de los pacientes con insuficiencia cardíaca.

Objetivo

The aim of the KardiaTool project is to translate a laboratory proven concept of a saliva biosensor to the clinical practice for addressing the priority needs in personalized HF diagnostics and therapy monitoring at the point of care. The KardiaTool platform includes: (i) An easy to use portable POC device (KardiaPOC) with a disposable Lab-on-a-Chip (LOC), for the non-invasive, rapid and accurate qualitative and quantitative assessment of HF biomarkers, from saliva samples. KardiaPOC device will integrate a variety of sensors, actuators, Microelectromechanical systems (MEMS), micro-electronics, bio-chemicals and functionalized magnetic nanoparticles (MNPs), onto a disposable, low cost LOC. (ii) A decision support software (KardiaSoft) based on predictive modelling techniques, that analyzes the POC data and other patient’s data, directly added by the healthcare professionals, and delivers information related to HF diagnosis and therapy monitoring. The innovation lays in the incorporation of four novel saliva biomarkers that have been proven in a laboratory setting and bring a new promising concept for addressing the priority needs of the clinical arena. KardiaPOC will provide the capability of simultaneously extracting key information from the saliva biomarkers: (i) NT-proBNP, (ii) TNF-a, (iii) Interleukin- 10, (iv) Cortisol. It is expected that identifying a comparable source to blood, for biomarker information, such as saliva, that is cost effective, less invasive, more convenient and acceptable for both patients and healthcare professionals would be beneficial for the healthcare community. The challenge of KardiaTool is: (i) to translate a laboratory proven concept of a saliva biosensor into an MNBS platform, for HF diagnostics and therapy monitoring, at the point of care, following GLP (ii) to validate the MNBS platform through pre-clinical and clinical testing following GCP and (iii) to industrialize the outcomes following GMP towards progress to marketization

Convocatoria de propuestas

H2020-NMBP-2016-2017

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-NMBP-X-KET-2017

Régimen de financiación

RIA - Research and Innovation action

Coordinador

UNIVERSITE LYON 1 CLAUDE BERNARD
Aportación neta de la UEn
€ 446 132,43
Dirección
BOULEVARD DU 11 NOVEMBRE 1918 NUM43
69622 Villeurbanne Cedex
Francia

Ver en el mapa

Región
Auvergne-Rhône-Alpes Rhône-Alpes Rhône
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 446 132,43

Participantes (16)